A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Intra-IMMUSG Pte Ltd
Intra-IMMUSG Pte Ltd
EMD Serono
City of Hope Medical Center
AstraZeneca
Astellas Pharma Inc
National Cancer Institute (NCI)
Amgen
Zymeworks BC Inc.
Seqker Biosciences, Inc.
Duke University
University of Florida
National Institutes of Health Clinical Center (CC)
University Hospital, Lille
Institut Paoli-Calmettes
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
M.D. Anderson Cancer Center
Hoffmann-La Roche
Bristol-Myers Squibb
Inova Health Care Services
Fenerbahce University
Istituto Giannina Gaslini
Case Comprehensive Cancer Center
NY Health d/b/a New York Cancer and Blood Specialists
Stiftelsen Stockholms Sjukhem
National Institutes of Health Clinical Center (CC)
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Stanford University
Amgen
Zhejiang Cancer Hospital
Institute of Oncology Ljubljana
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
European Organisation for Research and Treatment of Cancer - EORTC
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Tagworks Pharmaceuticals BV
Avenzo Therapeutics, Inc.
Institut de Cancérologie de Lorraine
Celtic Biotech Ltd